Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom.
Sign Up to like & getrecommendations! Published in 2019 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2019.04.018
Abstract: BACKGROUND Aclidinium bromide is an inhaled long-acting muscarinic antagonist (LAMA). Although the initial potential increased cardiovascular and mortality risk among users of tiotropium has been ruled out by several observational studies, and clinical trials, there… read more here.
Keywords: aclidinium; risk death; risk; among users ... See more keywords
Aclidinium bromide and formoterol fumarate for the maintenance treatment of chronic obstructive pulmonary disease
Sign Up to like & getrecommendations! Published in 2020 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2020.1717334
Abstract: ABSTRACT Introduction: Treatment options for COPD have evolved rapidly in the last decade and inhaled bronchodilators have largely supplanted the use of oral bronchodilators because of their increased efficacy and excellent safety with topical delivery… read more here.
Keywords: aclidinium; bromide formoterol; treatment; formoterol fumarate ... See more keywords